Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Jazz Pharmaceuticals
This study is a randomized, open-label, parallel-arm, fixed-dose, standard therapy controlled Phase IIB trial. Study enrollment duration is expected to be approximately 12-18 months. On entry, patients are randomized to receive either CPX-351 or standard induction treatment with cytarabine and daunorubicin("7 and 3" regimen). Patients are stratified to balance the likelihood of obtaining a CR and the duration of CR between the two arms.
Age
60–75
Sex
ALL
Healthy volunteers
Not accepted